Evidence map›Paper›PMID 22431590›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases.

Fiorenza Cocchi, Anthony L DeVico, Wuyuan Lu, Mikulas Popovic, Olga Latinovic, Mohammad M Sajadi, Robert R Redfield, Mark K Lafferty, Massimo Galli, Alfredo Garzino-Demo and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. The CD8Microbiology and molecular biology reviews : MMBR · 2021
    Review
  14. Canonical Wnts Mediate CD8Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  15. Review
  16. Review
  17. Review
  18. Analysis of the CD8Immunogenetics · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Fiorenza CocchiInstitute of Human Virology and Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Anthony L DeVico
Wuyuan Lu
Mikulas Popovic
Olga Latinovic
Mohammad M Sajadi
Robert R Redfield
Mark K Lafferty
Massimo Galli
Alfredo Garzino-Demo
Robert C Gallo
Institute of Human Virology · NGLuigi Sacco Hospital · ITUniversity of Maryland, Baltimore · US

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Training Grant in Cancer BiologyT32CA154274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Toni M Antalis, CURT I CIVIN · 2011 to 2026
$6.8M
IMMUNITY AND INFECTIONT32AI007540 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI KAPER, JAMES B · 1998 to 2018
$2.2M
A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS InfectionR01NS066842 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI GARZINO-DEMO, ALFREDO · 2009 to 2013
$1.7M
The circulating and memory B-antibody responses in HIV-infected patientsK23AI084580 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SAJADI, MOHAMMAD MOHSENI · 2010 to 2013
$539k
Discovery of soluble HIV suppressor factorsR21AI065330 · NIAID · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI COCCHI, FIORENZA · 2005 to 2006
$440k
NCI NIH HHS P30 CA134274NCI NIH HHS T32 CA154274NIAID NIH HHS K23 AI084580NIAID NIH HHS R21 AI065330NIAID NIH HHS R21AI065330-02NIAID NIH HHS T32 AI007540NIAID NIH HHS T32AI007540NINDS NIH HHS R01 NS066842NINDS NIH HHS R01NS066842
6 · The paper itself

Abstract

T-cell-derived soluble factors that inhibit both X4 and R5 HIV are recognized as important in controlling HIV. Whereas three β chemokines, regulated-on-activation normal T-cell expressed and secreted (RANTES), macrophage inflammatory protein (MIP)-1α, and MIP-1β, account for the suppression of R5 HIV by blockade of HIV entry, the major components responsible for the inhibition of X4 HIV strains have not been identified previously. We identify these factors primarily as a mixture of three β chemokines [macrophage-derived chemokine (MDC), thymus and activation-regulated chemokine (TARC), and I-309] and two RNases (angiogenin and RNase 4) of lesser potency and show that in a clade B population, some correlate with clinical status and are produced by both CD4(+) and CD8(+) T cells (chemokines, angiogenin) or only by CD8(+) T cells (RNase 4). The antiviral mechanisms of these HIV X4-suppressive factors differ from those of the previously described HIV R5-suppressive β chemokines.

Indexed as

Anti-HIV AgentsChemokines, CCDose-Response Relationship, DrugHIVHumansRibonucleasesSolubilityT-LymphocytesVirus ReplicationAnti-HIV AgentsChemokines, CCRibonucleases

Identifiers

PMID22431590
PMCPMC3325691
OpenAlexW2056530305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.